Connect with us

Cannabis News

White House Pushes Congress To Ensure ‘Fair Treatment Of Hemp Products’ By Calling Off Broad Recriminalization Law Set For November

Published

5 hours ago

on

The White House is pressing Congress to take action to prevent the sweeping federal recriminalization of hemp products that will take effect later this year.

The push comes as part of a request to lawmakers for additional funding to help the administration cover costs related to attacks on Iran and “other critical needs,” such as responding to an Ebola outbreak in Africa.

“Furthermore, the Administration is seeking additional authorities that it strongly supports,” White House Office of Management and Budget Director Russell Vought wrote to House Speaker Mike Johnson (R-LA) on Wednesday.

“These authorities include a review of federal hemp regulations to ensure fair treatment of hemp products consistent with Amendment 54 offered to HR 8646 in the House Rules Committee, or at least an extension of the implementation of the regulatory framework established by Section 781 of Public Law 119-37,” he said.

The amendment Vought was referring to was introduced by Rep. Andy Barr (R-KY). It has kept many hemp products legal that will be re-criminalized this yearadded labeling requirements and implemented new sales taxes, among other regulatory reforms. However, the Rules Committee prevented it from receiving a House vote.

Barr is also preparing to introduce stand-alone legislation on the issue and has said she opposes a coalition of strange bedfellows. the alcohol industry, marijuana businesses and opponents of cannabis legalization.

An appendix to the White House’s letter to Congress this week notes that the hemp-related request would “update the statutory definition of hemp-derived cannabinoid end products to ensure Americans have access to appropriate full-spectrum CBD products while maintaining Congress’ intent to limit the sale of products that pose serious health risks.”

The the administration used hemp-like language Earlier this month, they blocked retention of Barr’s previous amendment to the administration’s policy statement on the farm funding bill.

Jonathan Miller, general counsel of the US Hemp Desk, told Marijuana Moment that the group is “pleased to see the president take a public stance in favor of replacing the hemp ban with a strong regulatory framework, or at least securing an extension of the hemp ban moratorium to give Congress more time to develop regulations.”

“This is an important step in fulfilling Congress’ commitment to help farmers and consumers,” he said.

Hemp derivatives with less than 0.3 percent delta-9 THC by dry weight were made federally legal under the 2018 Farm Bill signed by Trump during his first term. But late last year, he signed new legislation with provisions that will redefine hemp, so that only products with a total of 0.4 milligrams of THC per container will remain legal starting November 12.

in April, the president himself has asked members of Congress to redefine hemp to prevent the recriminalization of full-spectrum CBD products.

“I call on Congress to update the Act so that Americans can continue to have access to the full-spectrum CBD products they trust and support, while upholding Congress’ intent to limit the sale of products that pose health risks,” Trump said in a Truth Social post the same day his administration announced it was moving forward with marijuana reregulation.

“We need to do this RIGHT and FAST, especially for those who have found CBD to help them,” he said. “Also, I’m told it will help our BIG FARMERS that we love and will always be around.”

Industry advocates say the law passed last year not only threatens to ban intoxicating and synthetic cannabinoids, but also take popular full-spectrum CBD products used therapeutically by many Americans off the market.

“ONE IN FIVE adults used it in the past year, and many say it dramatically improved their chronic pain,” the president said in the social media post, adding that hemp-derived CBD “has made a HUGE difference for so many people.”

The administration also referred to a new initiative launched in April Cover up to $500 of hemp-derived products annually for eligible Medicare patients. The program being implemented by the Centers for Medicare and Medicaid Services (CMS) focuses largely on CBD, but allows products to contain a total of 3 milligrams of THC per serving.

“In December, I signed a very important Executive Order calling for Research and Innovation into Hemp-derived CBD,” Trump said. “Our wonderful Dr. Mehmet Oz moved quickly to follow the Executive Order directive, and set a model in motion for some Seniors this month. But more needs to be done!”

“Please do it, and SOON,” the president said, referring to the sweeping recriminalization congressional fix that will take effect in November. “Thank you for your attention to this matter!”

It’s unclear how far Trump wants to reduce the scope of planned federal restrictions on hemp products and what kinds of revised THC rules and limits he’d prefer to sign into law.

Separately, White House officials recently briefed a congressional office on hemp regulation.

In April, Vince Haley, director of the White House Domestic Policy Council, and James Braid, assistant to the president for legislative affairs, sent Barr hemp policy suggestions.

“We appreciate your work to advance policy,” the executive order Trump signed in December, which included provisions to protect Americans’ access to CBD products, the staff wrote in a letter to Congress.

“We are submitting draft legislation and comments to your account to address the final statutory definition of hemp-derived cannabinoid products to ensure that Americans have access to adequate full-spectrum CBD products while maintaining Congress’ intent to limit the sale of products that pose serious health risks,” White House officials said, according to a social media screencast. “We are open to discussion and further technical assistance.”

Separately, Anti-marijuana organizations filed a lawsuit against the Medicare hemp CBD coverage policy– but adjudge dismissed the suit last month, ruling they lack standing. Health and Human Services lawyers section. Robert F. Kennedy Jr. and CMS director Mehmet Oz He filed a letter requesting that the case be dismissed.

The White House Management and Budget Office has also held a series of meetings a Food and Drug Administration (FDA) CBD product enforcement policy.

The FDA issued the guidance making it clear that it does not intend to interfere Establish a Medicare coverage plan for hemp-derived products.

CMS finalized a rule that will be adopted separately Coverage of certain hemp products, primarily as specialized health-related benefits, through Medicare Advantage the plans

As hemp products become more popular among consumers, some big brands are trying to get in on the action.

The main retailer Target, for example, is expanding its market share of hemp-derived THC beverages. Last year, the company began a pilot program selling cannabis beverages at 10 stores in Minnesota. That apparently went well, and now the company has secured licenses from Minnesota regulators to sell lower-potency edible hemp products — including THC drinks — in 72 stores in the state.

The National Restaurant Association, which represents the industry, just sent a letter to congressional leaders asking for it delaying the federal recriminalization of hemp THC beverages It will come into effect at the end of the year and will be replaced by a regulatory framework that “meets growing market demand while ensuring consumer safety” as an alternative to alcohol in products.

A report from the US Department of Agriculture published in April shows this US farmers grow $3 billion in hemp crops by 2025— 64% increase compared to the previous year.

Read the White House the letter To the conference below:

Marihuana Moment is made possible with the help of readers. If you rely on our pro-cannabis journalism to stay informed, consider a monthly Patreon pledge.

Related Topics:
Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Cannabis News

Good Behavior dispensary applies to open in Yorkville

Published

5 hours ago

on

June 25, 2026

By











A cannabis company called Good Behavior is seeking approval from the city of Yorkville, Illinois, to open a dispensary on a 0.93-acre plot along Saravanos Drive, west of South Bridge Street and south of Stagecoach Trail, becoming the latest entrant in a string of cannabis proposals the city has previously rejected. The company has filed a special-use application with the city and is staking its case on the tax revenue a dispensary would generate for Yorkville.

Full details of the application, including projected tax figures, the company’s ownership structure and details of any board discussions, are available to Shaw Local News Network subscribers. The article, reported by Shaw Local News Network’s Joey Weslo and published on June 23, 2026, notes that cannabis companies had previously failed to get city approval before Good Behavior presented its proposal.

The proposed site places the dispensary in a commercial corridor to the south of the city. Good Behavior’s application requires a special use permit from Yorkville before the project can proceed.

Source: local Shaw










Continue Reading

Cannabis News

Guido de Buijn (Agrofair) consolidates his leading position, whilst fruit and vegetable lawyer Hans Borsboom enters the top five

Published

1 day ago

on

June 24, 2026

By






FreshPublishers 2026 World Cup Group Stage






Today, it is the Dutch who are making their mark in the Fresh Publishers’ World Cup rankings. Guido de Bruijn, Agrofair’s account manager, correctly predicted the results of the Argentina – Austria and France – Iraq matches, thus consolidating his leadership. He is followed by quality controller Mark Libregts of JNV Produce, while food and agriculture specialist Cindy van Rijswick of Rabobank has once again rounded out the top three. In fourth place is Dirk van den Hurk, aaff’s relationship manager. He has a three-point lead over fruit and vegetable lawyer Hans Borsboom, who is competing under the name HerikLegal United. Interestingly, the main contestants predict very different winners. Guido supports Portugal, Mark supports France, Cindy supports Germany and Dirk and Hans support Spain.

In sixth place is Seth Karstens, who manages retail sales for Gerbera United. Marcos Miedema – again from Agrofair – is seventh, ahead of Andre Filippov from the German company Global Fruit Point. Rob Welles of plant grower Ovata and Italian potato and vegetable trader Luigi Giacomello have slipped a little further up the table and are in ninth and tenth place. However, there is still a long way to go to win the 1,000 euros. Starting with the next four matches: Portugal – Uzbekistan, England – Ghana, Panama – Croatia and Colombia – Congo.

© FreshPublishers



Publication date:













Continue Reading

Cannabis News

Marijuana Moment Asks DEA Judge To Allow Livestreaming Of Rescheduling Hearing For Transparent Public Access

Published

1 day ago

on

June 24, 2026

By

Marijuana Moments is asking a Drug Enforcement Administration (DEA) judge to reconsider his decision hearings on the Trump administration’s cannabis deregulation proposal begin next week and features only the opponents of the reform as invited participants.

Chief Administrative Law Judge Derek Julis last week issued a preliminary order setting out the rules and timelines for the marijuana reorganization proceeding, recognizing at the same time that “the national public interest in this matter favors a policy of transparency” and, at the same time, specifying that “the hearing will not be televised, live or otherwise.”

As a result, people who want to see the historic cannabis reform process must go directly to Arlington, Virginia, by court order.

In a letter to Julius on Tuesday, Marijuana Moment counsel Joseph Bondy noted that the DEA had previously authorized, then canceled the hearing process, the Biden administration’s proposal to move cannabis from Schedule I to the Controlled Substances (CSA) Schedule III.

“That prior decision was correct. The public interest rationale for contemporary access has not diminished,” Bondy wrote. “If the DEA believes that security, witness management, or operational concerns require a more restrictive access regime, those concerns should be identified and addressed through narrow requirements rather than a categorical ban.”

“Arlington’s limited physical seating is not a meaningful substitute for a live broadcast. Marijuana Moments, like much of the press and public following federal cannabis policy nationally, cannot rely on the few available seats as a practical way to observe and report on the hearing. This is precisely why the DEA’s advance live broadcast was important: it allowed them to follow these directives without physically obstructing the venue. burdening security, or making anyone a party.”

“In a proceeding of this public importance, and in light of the DEA’s prior direct directive, the public hearing is not publicly accessible if the case is based on limited physical attendance,” Marijuana Moment’s attorney wrote to the DEA judge. “Delayed access to transcripts is no substitute for timely observation. The press reports events as they unfold. The public evaluates government action in real time. And in a proceeding of this magnitude, transparency is not a courtesy. It’s a guarantee.”

“For a large public audience seeking serious coverage of federal cannabis policy, Marihuana Moment is an important channel through which the public can understand these proceedings.”

The letter makes clear that Marihuana Moments “does not seek to participate as a party, present evidence, examine witnesses, present proposed findings, or alter the schedule of merits” and “seeks only temporary public and press access to an administrative hearing of recognized national public interest.”

Bondy asked Julius for an answer by Thursday.

—
Marijuana Moment’s journalism is made possible by readers like you, who value this work enough to support us monthly pledges on Patreon. If you rely on our reports to stay informed of important developments in cannabis, please help us do this becoming a permanent subscriber today.

Backing us at the $25/month level, you’ll have access to our Bill Tracker so you don’t miss any important marijuana legislation in your state.
—

Meanwhile, he is also a lawyer A representative of a major cannabis reform organization is calling for the DEA to reconsider decision to participate in the hearing as an interested party.

The National Organization for Reform of Marijuana Laws (NORML), which represents the interests of people who use cannabis, filed an “emergency petition for reconsideration” through Bondy on Friday, saying “the public interest will be significantly harmed if the registry ignores the consumer perspective.”

The DEA made the announcement last week Only select participants—and opponents of reform—have been invited to the marijuana redistricting hearing to participate, and some of them have filed a lawsuit trying to block the reform. Supporters of the reform who expressed their intention to participate were not invited.

“NORML’s rejection, if not addressed immediately, will deprive NORML and the cannabis consumers it represents of meaningful participation in hearing proceedings, the presentation of witnesses, the designation of exhibits, cross-examination, legal briefs, and any other proceedings necessary to complete a complete record,” wrote Bondy, NORML director Terrance as chairman of the DEA’s board of directors. “Prejudice is immediate. It cannot be cured after the hearing is closed.”

According to several rejection letters seen by Marijuana Moment from cannabis reform advocates, the DEA said they do not meet the definition of “interested person” to participate because they “would not be harmed or harmed by any rule or proposed rule that may be issued.”

NORML said in its request for reconsideration, however, that “DEA’s denial is based on a flawed premise: that NORML has not been harmed or prejudiced by the proposed rule because NORML allows marihuana to be removed from Schedule I and Schedule III.

“That is not NORML’s position. NORML supports delisting from schedule I. But NORML does not support schedule III as the final correct federal treatment of marijuana,” Bondy wrote. “NORML’s position is that marijuana should be removed from the CSA schedules and regulated under a specific federal framework that addresses public health, consumer safety, product integrity, youth prevention, truthful labeling, testing, access to research, impaired driving policy, diversion, state-regulated market realities, and illegal displacement.”

The lawyer wrote that the injury to marijuana’s Schedule III status “is not a mere ideological desperation.”

“NORML members would remain subject to federal controlled substance status and the legal consequences that flow from it. Adult consumers who legally participate in state-regulated markets would be excluded from consistent federal recognition,” Bondy said. “Schedule III would keep illegal federal cannabis activity outside of federally authorized medical, research, or registrar channels. It would continue to cause federal-state conflict, public confusion, stigma, side effects, and harm to consumer safety.”

The hearing it will start on June 29 and end before July 15.

Acting Attorney General Todd Blanche in April He issued an order that immediately reclassified the state’s licensed medical cannabisas well as marijuana products approved by the Food and Drug Administration (FDA) under Schedule I through Schedule III of the Controlled Substances Act (CSA).

According to a separate order signed by the acting attorney general, the upcoming hearing will include Class III marijuana.

In order to be considered for participation in the hearing, the parties had to submit requests, indicating their interest in the procedure, the claims or issues they want to hear and their position on these issues.

“The purpose of the hearing is to ‘receive factual evidence and expert opinion’ on whether marijuana should be transferred to Schedule III of the controlled substance list,” Blanche’s initial statement in April said.

The attorney general also selected an administrative law judge (ALJ) to oversee the proceedings.

“The ALJ’s authority includes the power to hold conferences to simplify or determine the issues at the hearing or to consider other matters that may assist in the expeditious resolution of the hearing; to require the parties to state their position in writing; to sign and issue subpoenas; to compel the production of documents and materials to the extent necessary to conduct the hearing; to examine witnesses; to direct, exclude, or testify; the Rule on Procedural Matters and the President’s DEA Hearing Procedures and Administrative Procedure Actions allowed under the law, Blanch wrote.

Preliminary hearing process on the marijuana redistricting process initiated by the Biden administration It was halted last year amid allegations of improper communications and witness selection.

the current The marijuana redistricting process is being challenged in several ways which have been upheld by a federal Court of Appeals. those pieces of State attorneys general have filed lawsuits against cannabis reform, Opponents of marijuana legalization and a a cannabis-based biopharmaceutical corporation.

Meanwhile, the reorganization of state-licensed medical cannabis is already having a major impact.

The Congressional Research Service published a report on the current rescheduling of cannabis Certified patients with medical marijuana from state licensed dispensaries are now eligible for Class III. “The order appears to allow end users to use marijuana medically without a CSA prescription,” he says.

The Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF) has published a Draft update to a gun purchase form to recognize the legal status of medical marijuana in the reprogramming. The revised section of the question states that only the “recreational use or possession of marijuana” is federally prohibited, omitting the prior form’s mention of medical cannabis.

The US Treasury and Internal Revenue Service (IRS) said they plan to issued new tax guidelines for the marijuana industry after reprogramming. The reform will benefit state-licensed marijuana businesses by allowing them to take federal tax deductions that are currently prohibited under IRS Code Section III, known as Section 280E.

Even the DEA, which has long opposed cannabis legalization and accused the Biden administration of stalling the initiative in the reorganization process, has done so. It launched a registration process for legal marijuana businesses in the state to take advantage of the federal benefits that come with the reform.

The Department of Transport, on the other hand, issued guidelines stating this use Legal medical cannabis in the state is still no excuse for truck drivers to test positive for drugspilots and other safety-sensitive personnel.

A congressional committee recently Federal officials voted to block further steps to reschedule cannabis.

read it the letter Marijuana Moment’s attorney to the DEA judge below:

Marihuana Moment is made possible with the help of readers. If you rely on our pro-cannabis journalism to stay informed, consider a monthly Patreon pledge.

Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media